Newsroom

Categories: COVID-19, Drug Discovery & Development

Arctoris contributes its capabilities and expertise to the fight against COVID-19

July 14, 2020

Categories: Drug Discovery & Development, Corporate, Finance & Investor

My Personal Therapeutics and Pentavere receive EUREKA Artificial Intelligence/Quantum Therapeutics funding to support the development of My Personal Therapeutics’s digital therapeutics for lung cancer

July 1, 2020

Categories: Drug Discovery & Development, Corporate, Finance & Investor

Sygnature Discovery boosts senior management team with appointment of Dr Paul Overton

June 23, 2020

Categories: COVID-19, Drug Discovery & Development

Sygnature Discovery assists New York Medical College in the fight against COVID-19

June 11, 2020

Categories: Drug Discovery & Development, Corporate, Finance & Investor

Sygnature expands capabilities with acquisition of Alderley Oncology

June 3, 2020

Categories: COVID-19, Drug Discovery & Development

NanoPass is joining forces with pharma partners in the fight against the COVID-19 pandemic

April 27, 2020

Categories: Biotechnology, Drug Discovery & Development, Pharma

Pathios Therapeutics announces appointment of Dr. Tobias Bopp as the foundational member of its Scientific Advisory Board

February 11, 2020

Categories: Biotechnology, Drug Discovery & Development, Pharma, Clinical Research & Trials

Inceptua Appoints New Head of Asia-Pacific, Clinical Trial Services

February 3, 2020

Categories: Bioprocessing, Biomanufacturing, Biotechnology, Drug Discovery & Development, Pharma

Applied Photophysics board appoints Tim Flanagan as CEO

February 3, 2020